Sutro Biopharma (STRO) Q2 2023 Earnings Report

742 Followers

STRO Q2 2023 EPS Results

Actual EPS-$6.40

Consensus EPS-$7.33

Beat/MissBeat by +$0.92

One Year Ago EPS-$5.50

Actual Revenue$10.41M

Expected Revenue$12.56M

Beat/MissMissed by -$2.15M

YoY Revenue Growth-62.94%

QuarterQ2 2023

Date08/10/2023

TimeAfter Close

Conference CallThursday, August 10, 2023

STRO Upcoming Earnings

Sutro Biopharma's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	-1.66 / -	-6.7	―
Aug 12, 2026	2026 (Q2)	-2.19 / -2.33	-1.4	-66.43% (-0.93)
May 14, 2026	2026 (Q1)	-2.74 / -2.94	-9.1	67.69% (+6.16)
Mar 23, 2026	2025 (Q4)	-8.16 / -5.29	-8.3	36.27% (+3.01)
Nov 06, 2025	2025 (Q3)	-3.94 / -6.70	-5.9	-13.56% (-0.80)
Aug 07, 2025	2025 (Q2)	-3.82 / -1.40	-5.9	76.27% (+4.50)
May 08, 2025	2025 (Q1)	-6.43 / -9.10	-9.5	4.21% (+0.40)
Mar 13, 2025	2024 (Q4)	-8.30 / -8.30	5.2	-259.62% (-13.50)
Nov 13, 2024	2024 (Q3)	-7.35 / -5.90	-8.1	27.16% (+2.20)
Aug 13, 2024	2024 (Q2)	-7.92 / -5.90	-6.4	7.81% (+0.50)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed